Back
NV5 Global Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
31
NVEE
NV5 Global
Last Price:
$17.35
Seasonality Move:
11.52%
Buy
54
DRUG
Bright Minds Biosciences
Last Price:
$35.92
Seasonality Move:
-28.52%
Sell
31
NV5 Global (NVEE)
is a Sell
Is NV5 Global a Buy, Sell or Hold?
-
The current NV5 Global [NVEE] share price is $17.41. The Score for NVEE is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
NVEE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Bright Minds Biosciences (DRUG)
is a Buy
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $36.25. The Score for DRUG is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVEE Stock Price Chart
What is NV5 Global's stock price today?
-
The NV5 Global share price today is $17.41Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVEE is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $36.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVEE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 41.91 | Sell |
Chaikin Money Flow: | -834141 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.43 - 18.21) | Sell |
Bollinger Bands (100): | (17.93 - 22.39) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.82 | Sell |
Relative Strength Index (14 RSI): | 50.3 | Buy |
Chaikin Money Flow: | 47724 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.85 - 42.25) | Sell |
Bollinger Bands (100): | (33.67 - 45.15) | Sell |
NVEE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.78 | Sell |
20-day SMA: | 17.76 | Sell |
50-day SMA: | 18.25 | Sell |
200-day SMA: | 21.84 | Sell |
8-day EMA: | 17.78 | Sell |
20-day EMA: | 17.88 | Sell |
50-day EMA: | 18.52 | Sell |
200-day EMA: | 21.26 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.16 | Buy |
20-day SMA: | 37.2 | Sell |
50-day SMA: | 37.07 | Sell |
200-day SMA: | 20.27 | Buy |
8-day EMA: | 35.28 | Buy |
20-day EMA: | 36.12 | Buy |
50-day EMA: | 36.52 | Sell |
200-day EMA: | 24.96 | Buy |
NV5 Global Earnings Growth & NVEE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.85 per share, and a decrease next year of $2.17 per share.
NV5 Global Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |